Seasonal flu vaccination for people aged 65 and over in France. Role of the Efluelda and Fluad vaccines

The French Health Authority (HAS) recommends that Efluelda and Fluad vaccines be used preferentially in people aged 65 and over, compared to the standard-dose vaccines available in this population, as part of the French seasonal flu vaccination strategy. 

The HAS positions adjuvanted and high-dose vaccines equally. The HAS specifies that this preferential recommendation does not exclude standard-dose vaccines from the flu vaccination strategy for people aged 65 and over.